Scientific Publications
Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
Muik, A., Stubbert, L.J., Jahedi, R.Z., Geiß, Y., Dold, C., Tober, R., Volk, A., Klein, S., Dietrich, U., Yadollahi, U., Falls, T., Miletic, H., Stojdl, D., Bell, J.C. & von Laer, D. A highly potent chimeric oncolytic virus for the treatment of brain cancer. Cancer Res, 74(13):3567-78 (2014)
VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications
Tober, R., Banki, Z., Egerer, L., Muik, A., Behmüller, S., Kreppel, F., Greczmiel, U., Oxenius, A., von Laer, D. & Kimpel, J. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. J Virol, 88(9):4897-907 (2014)
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
Muik, A., Dold, C., Geiß, Y., Volk, A., Werbizki, M., Dietrich, U. & von Laer, D. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy. J Mol Med (Berl), 90(8):959-70 (2012)
Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
Muik, A., Kneiske, I., Werbizki, M., Wilflingseder, D., Giroglou, T., Ebert, O., Kraft, A., Dietrich, U., Zimmer, G., Momma, S. & von Laer, D. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J Virol, 85(11):5679-84 (2011)